腫瘍学におけるAI市場規模、シェア、動向分析レポート：コンポーネントタイプ別、がんタイプ別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

腫瘍学におけるAI市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、腫瘍学におけるAIの世界市場規模は、2024年から2030年にかけて28.92％のCAGRを記録し、2030年までに191億7,000万米ドルに達すると予測されています。

同市場は、世界人口の間でがんの有病率が増加しており、がんの診断、治療、分析を行う技術的に高度な製品を開発する必要性が高まっていることから、大きな成長が見込まれています。例えば、国際がん研究機関（IARC）は、2023年に2,070万人以上の新規患者が発生すると予測しています。さらに、AIは早期発見を可能にし、特に効率的な検診プログラムを通じて死亡率を低下させるために極めて重要です。

新興市場では、ライフスタイルの変化や人口の高齢化など様々な要因により、がんの有病率が上昇しています。これらの市場におけるがん患者の急増は、早期発見、個別化治療、全体的な患者の転帰を改善するために、腫瘍学におけるAIのような先進技術に対する需要を生み出しています。例えば、2024年1月、インド初のAI精密腫瘍学センター（POC）がベンガルールのアポロがんセンターで開設されました。このPOCは、AIが提供する膨大な可能性を活用し、腫瘍医、患者、介護者が指定された時間内に可能な限り最良の結果を達成できるよう支援します。

AIは、マルチオミクス解析による膨大なデータセットを、ディープラーニングや高性能コンピューティング技術の最新開発と統合することで、腫瘍学の分野に変革をもたらしつつあります。AIの応用は、新たな検出、スクリーニング、診断、分類アプローチ、がんゲノミクスの特徴づけ、腫瘍微小環境の解析、予後・予測バイオマーカー評価、経過観察・創薬戦略などへと拡大しています。例えば、2022年10月、Model Medicines社は、固形および血液悪性腫瘍への応用に焦点を当て、2つのエピジェネティックおよび発がん性標的に対する治療薬の同定と開発に焦点を当てた腫瘍学プログラムを開始しました。

同市場で事業を展開する主要企業は、がんの早期診断の補助、需要の高まりへの対応、研究開発パイプラインの強化のため、新製品の開発に重点を置いた提携や共同研究などの戦略を採用しています。例えば、2022年12月、アストラゼネカはクリニシンクと提携し、肺がんのAIプロジェクトを立ち上げました。このプロジェクトは、肺がんを早期に発見し、効果的な治療法の開発を支援することを目的としています。

さらに2022年11月には、グーグルヘルスがiCAD社とパートナーシップを結び、同社の人工知能技術を用いた乳がん検診の改善に取り組んでいます。さらに、多くの公的機関や民間団体が、AIベースの腫瘍学スクリーニング製品の研究開発に対する資金提供や投資に注力しています。例えば、2023年3月、Artera社は、限局性前立腺がんの治療を予測するために初めて開発された検査であるArteraAI Prostate Testの発売と販売のために9,000万米ドルの資金提供を受けた。

腫瘍学におけるAI市場レポートハイライト

• コンポーネントの種類別では、ソフトウェアソリューション分野が予測期間中に最も速いCAGRで成長すると予測されます。
• がんの種類別に見ると、前立腺がん分野は、人口の間で有病率が上昇しており、予測期間中に最も速いCAGRで成長すると予測されています。CDCが発表したデータによると、前立腺がんは一般的に米国では100人中13人の男性が罹患しています。
• 用途別では、研究開発分野が予測期間中に有利なCAGRで成長する見込みです。これは、製薬会社における高度なAI対応アルゴリズムの広範な採用と融合に起因します。
• 最終用途別では、病院が市場を独占し、最も速い成長を記録しました。これは、病院においてAIを活用したがん治療ソリューションを共同開発または導入する企業が増加しているためです。
• 北米は、患者にデジタルソリューションを提供するための有利な政府のイニシアチブとデジタルインフラが利用可能であるため、市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腫瘍学におけるAI市場の変数、動向、および範囲

• 市場系統の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 事業環境分析
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
• COVID-19が腫瘍学市場におけるAIに与える影響

第4章 腫瘍学におけるAI市場セグメント分析、コンポーネント別

• 定義と範囲
• コンポーネントセグメントダッシュボード
• 腫瘍学市場における世界のAIコンポーネント別、2018年から2030年
• ソフトウェアソリューション
  • ソフトウェアソリューション市場、2018～2030年
• ハードウェア
  • ハードウェア市場、2018～2030年
• サービス
  • サービス市場、2018～2030年

第5章 腫瘍学におけるAI市場セグメント分析、がんの種類別

• 定義と範囲
• がんの種類セグメントのダッシュボード
• 市場規模、予測および動向分析、2018年から2030年まで
• 乳がん
  • 乳がん市場推計・予測、2018～2030年
• 肺がん
  • 肺がん市場推計・予測、2018～2030年
• 前立腺がん
  • 前立腺がん市場推計・予測、2018～2030年
• 結腸直腸がん
  • 結腸直腸がん市場推計・予測、2018年から2030年
• 脳腫瘍
  • 脳腫瘍市場推計・予測、2018年から2030年
• その他
  • その他の市場推計・予測、2018-2030

第6章 腫瘍学におけるAI市場セグメント分析、用途別

• 定義と範囲
• 用途セグメントダッシュボード
• 市場規模、予測および動向分析、2018年から2030年まで
• 診断（病理学、がん放射線学）
  • 診断
• 放射線療法（放射線療法）
  • 放射線治療
• 研究開発（創薬、開発プロセスなど）
  • 研究開発
• 化学療法
  • 化学療法市場推計・予測、2018～2030年
• 免疫療法
  • 免疫療法市場推計・予測、2018～2030年

第7章 腫瘍学におけるAI市場セグメント分析、最終用途タイプ別

• 定義と範囲
• 最終用途セグメントダッシュボード
• 市場規模、予測および動向分析、2018年から2030年まで
• 病院
  • 病院市場、2018～2030年
• 外科センターおよび医療機関
  • 手術センターおよび医療機関の市場推計・予測、2018～2030年
• その他（製薬会社、調査機関、研修センター）
  • その他

第8章 腫瘍学におけるAI市場セグメント分析、地域別、コンポーネント別、がんの種類別、用途別、最終用途別

• 定義と範囲
• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析
• 北米
  • 北米の腫瘍学におけるAI市場、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 欧州の腫瘍学におけるAI市場、2018～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋地域の腫瘍学におけるAI市場、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカの腫瘍学におけるAI市場、2018～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカの腫瘍学におけるAI市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 腫瘍学におけるAI市場-競合分析

• 主要市場参入企業による最近の動向と影響分析
• 企業の分類
• 企業プロファイル
  • Azra AI
  • IBM
  • Siemens Healthcare GmbH
  • Intel Corporation
  • GE HealthCare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • ConcertAI
  • Median Technologies
  • PathAI

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global AI in oncology market, by region, 2018 - 2030 (USD Million)
• Table 4 Global AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 5 Global AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 6 Global AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 7 Global AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 8 North America AI in oncology market, by region, 2018 - 2030 (USD Million)
• Table 9 North America AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 10 North America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 11 North America AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 12 North America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 13 U.S. AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 14 U.S. AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 15 U.S. AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 16 U.S. AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 17 Canada AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 18 Canada AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 19 Canada AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 20 Canada AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 21 Europe AI in oncology market, by region, 2018 - 2030 (USD Million)
• Table 22 Europe AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 23 Europe AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 24 Europe AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 25 Europe AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 26 Germany AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 27 Germany AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 29 Germany AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 30 UK AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 31 UK AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 32 UK AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 33 UK AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 34 France AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 35 France AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 36 France AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 37 France AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 38 Italy AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 39 Italy AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 40 Italy AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 41 Italy AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 42 Spain AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 43 Spain AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 44 Spain AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 45 Spain AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 46 Denmark AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 47 Denmark AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 48 Denmark AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 49 Denmark AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 50 Sweden AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 51 Sweden AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 52 Sweden AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 53 Sweden AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 54 Norway AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 55 Norway AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 56 Norway AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 57 Norway AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific AI in oncology market, by region, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 63 China AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 64 China AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 65 China AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 66 China AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 67 Japan AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 68 Japan AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 69 Japan AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 70 Japan AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 71 India AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 72 India AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 73 India AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 74 India AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 75 South Korea AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 76 South Korea AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 77 South Korea AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 78 South Korea AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 79 Australia AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 80 Australia AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 81 Australia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 82 Australia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 83 Thailand AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 84 Thailand AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 85 Thailand AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 86 Thailand AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 87 Latin America AI in oncology market, by region, 2018 - 2030 (USD Million)
• Table 88 Latin America AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 89 Latin America AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 90 Latin America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 91 Latin America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 92 Brazil AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 93 Brazil AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 94 Brazil AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 95 Brazil AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 96 Mexico AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 97 Mexico AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 98 Mexico AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 99 Mexico AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 100 Argentina AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 101 Argentina AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 102 Argentina AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 103 Argentina AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 104 MEA AI in oncology market, by region, 2018 - 2030 (USD Million)
• Table 105 MEA AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 106 MEA AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 107 MEA AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 108 MEA AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 109 South Africa AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 110 South Africa AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 111 South Africa AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 112 South Africa AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 117 UAE AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 118 UAE AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 119 UAE AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 120 UAE AI in oncology market, by end-use, 2018 - 2030 (USD Million)
• Table 121 Kuwait AI in oncology market, by component, 2018 - 2030 (USD Million)
• Table 122 Kuwait AI in oncology market, by application, 2018 - 2030 (USD Million)
• Table 123 Kuwait AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
• Table 124 Kuwait AI in oncology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 AI in Oncology Market Segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Commodity flow analysis
• Fig. 5 Parent market analysis
• Fig. 6 AI in oncology Market snapshot
• Fig. 7 AI in oncology Market segment snapshot
• Fig. 8 AI in oncology Market segment snapshot
• Fig. 9 AI in oncology Market competitive landscape snapshot
• Fig. 10 Market research process
• Fig. 11 Parent market outlook (USD Billion) (2023)
• Fig. 12 AI in oncology market dynamics
• Fig. 13 Areas of interest most likely to benefit from AI in the next 10 years
• Fig. 14 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
• Fig. 15 Comparison between AI-integrated healthcare and traditional healthcare
• Fig. 16 Porter's Analysis
• Fig. 17 PESTEL Analysis
• Fig. 18 AI in oncology market, component outlook key takeaways (USD Million)
• Fig. 19 AI in oncology market: Component movement analysis, 2023 & 2030 (USD Million)
• Fig. 20 Software solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Hardware market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 AI in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
• Fig. 24 AI in oncology market: Cancer type movement analysis, 2023 & 2030 (USD Million)
• Fig. 25 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Brain tumor market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 AI in cancer diagnostics market, application outlook key takeaways (USD Million)
• Fig. 32 AI in oncology market: Application movement analysis, 2023 & 2030 (USD Million)
• Fig. 33 Diagnostics (pathology, cancer radiology) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Radiation therapy (Radiotherapy) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Research & development market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 AI in oncology market, end-use outlook key takeaways (USD Million)
• Fig. 39 AI in oncology market: End-user movement analysis, 2023 & 2030 (USD Million)
• Fig. 40 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Surgical centers and medical institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Regional marketplace: Key takeaways
• Fig. 44 AI in Oncology market: Regional outlook, 2023 & 2030 (USD Million)
• Fig. 45 AI in Oncology market: Regional outlook, 2023 & 2030 (USD Million)
• Fig. 46 North America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 US AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 US AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Canada AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Europe AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 UK AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Fig.54 Key country dynamics
• Fig. 56 Germany AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Fig.56 Key country dynamics
• Fig. 58 Spain AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 France AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Italy AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Norway AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Denmark AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Sweden AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Asia Pacific AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Japan AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 China AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 India AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 Australia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 South Korea AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Thailand AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Latin America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 Brazil AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Mexico AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
• Fig. 87 Key country dynamics
• Fig. 88 Argentina AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 MEA AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 South Africa AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 Saudi Arabia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 UAE AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 Kuwait AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Key company categorization
• Fig. 99 Heat map analysis, 2022 - 2023

AI In Oncology Market Growth & Trends:

The global AI in oncology market size is expected to reach USD 19.17 billion by 2030, registering a CAGR of 28.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically advanced products to diagnose, treat, and analyze cancer. For instance, the International Agency for Research on Cancer (IARC) expects over 20.7 million new cases in 2023. Moreover, AI enables early detection, crucial for lowering mortality, especially through efficient screening programs.

Emerging markets are witnessing a rising prevalence of cancer due to various factors, including lifestyle changes & aging populations. The surge in cancer cases in these markets creates a demand for advanced technologies like AI in oncology to improve early detection, personalized treatment, and overall patient outcomes. For instance, in January 2024, India's first AI-Precision Oncology Centre (POC) was launched at Apollo Cancer Centre in Bengaluru. The POC will utilize the vast possibilities offered by AI to help oncologists, patients, and caregivers achieve the best possible results within a specified time frame.

AI is transforming the field of oncology by integrating vast datasets from multi-omics analyses with the latest developments in deep learning and high-performance computing techniques. AI applications are expanding to include new detection, screening, diagnosis, and classification approaches, cancer genomics characterization, tumor microenvironment analysis, prognostic and predictive biomarkers assessment, and strategies for follow-up and drug discovery. For instance, in October 2022, Model Medicines launched an oncology program focusing on identifying and developing therapeutics against two epigenetic and oncogenic targets, focusing on applications for solid and hematological malignancies.

The major players operating in the market are adopting strategies such as collaborations and partnerships with a major focus on development of newer products to aid in the early diagnosis of cancer, meet rising demand, and enhance research and development pipeline. For instance, in December 2022, AstraZeneca collaborated with Clinithink to launch an AI project for lung cancer. This project aims to detect lung cancer at an early stage to aid in the developing of effective treatment.

Furthermore, in November 2022, Google Health entered into a partnership with iCAD, Inc. for the improvement of breast cancer screening using the company's artificial intelligence technology. Additionally, a number of public and private organizations are focusing on funding and investment for R&D in AI-based oncology screening products. For instance, in March 2023, Artera received funding of USD 90 million for the launch and distribution of the ArteraAI Prostate Test, the first developed test for predicting therapy in localized prostate cancer.

AI In Oncology Market Report Highlights:

• Based on component type, the software solutions segment is anticipated to grow at the fastest CAGR over the forecast period, owing to increasing adoption of software solutions for a wide number of applications due to the better outcomes offered by this component
• Based on cancer type, the prostate cancer segment is anticipated to grow at the fastest CAGR over the forecast period in the market with rising prevalence amongst the population. Prostate cancer generally affects 13 out of every 100 men in the U.S., according to the data published by CDC
• Based on application type, the research and development segment is expected to grow at the lucrative CAGR over the forecast period. This is attributable to the widespread adoption and amalgamation of advanced AI-enabled algorithms in pharmaceutical companies
• Based on end-use, the hospitals dominated the market and registered the fastest growth owing to growing number of companies collaborating or introducing AI-powered cancer care solutions in hospitals
• North America dominated the market due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
  • 2.2.1. Component outlook
  • 2.2.2. Cancer type outlook
  • 2.2.3. Application outlook
  • 2.2.4. End-use outlook
• 2.3. Competitive Landscape Snapshot

Chapter 3. AI In Oncology Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing demand for early detection and classification of cancer
    • 3.2.1.1.1.Case study 1
    • 3.2.1.1.2.Case study 2
    • 3.2.1.2. Increasing prevalence of cancer
    • 3.2.1.2.1.Breast
    • 3.2.1.2.2.Barain & CNS
    • 3.2.1.2.3.Kidney
    • 3.2.1.2.4.Non-Hodgkin lymphoma
    • 3.2.1.2.5.Bladder
    • 3.2.1.2.6.Colon & rectum
    • 3.2.1.2.7.Prostate
    • 3.2.1.2.8.Case Study 3
    • 3.2.1.3. Rising adoption of precision medicine
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High procurement and implementation cost
    • 3.2.2.2. Lack of skilled workforce
    • 3.2.2.3. High impact of regulations
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
• 3.4. Impact of COVID-19 on AI in Oncology Market

Chapter 4. AI In Oncology Market Segment Analysis, By Component, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Component Segment Dashboard
• 4.3. Global AI In Oncology Market, by Component, 2018 to 2030
• 4.4. Software Solution
  • 4.4.1. Software Solution Market, 2018 - 2030 (USD Million)
• 4.5. Hardware
  • 4.5.1. Hardware Market, 2018 - 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. AI In Oncology Market Segment Analysis, By Cancer Type, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Cancer Type Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.4. Breast Cancer
  • 5.4.1. Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
• 5.5. Lung Cancer
  • 5.5.1. Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
• 5.6. Prostate Cancer
  • 5.6.1. Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
• 5.7. Colorectal Cancer
  • 5.7.1. Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
• 5.8. Brain Tumor
  • 5.8.1. Brain tumor market estimates and forecast, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. AI In Oncology Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. Application Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.4. Diagnostics (Pathology, Cancer Radiology)
  • 6.4.1. Diagnostics (pathology, cancer radiology) market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Radiation Therapy (Radiotherapy)
  • 6.5.1. Radiation therapy (radiotherapy) market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Research & Development (Drug Design, Development Process, etc.)
  • 6.6.1. Research & development (drug design, development process, etc.) market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. Chemotherapy
  • 6.7.1. Chemotherapy market estimates and forecast, 2018 - 2030 (USD Million)
• 6.8. Immunotherapy
  • 6.8.1. Immunotherapy market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. AI In Oncology Market Segment Analysis, By End-use Type, 2018 - 2030 (USD Million)

• 7.1. Definitions and Scope
• 7.2. End-use Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.4. Hospitals
  • 7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 7.5. Surgical Centers & Medical Institutes
  • 7.5.1. Surgical centers & medical institutes market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Others (Pharmaceutical Companies, Research Institutes & Training Centers)
  • 7.6.1. Others (pharmaceutical companies, research institutes & training centers) market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. AI In Oncology Market Segment Analysis, By Region, By Component, By Cancer Type, By Application, By End-use, 2018 - 2030 (USD Million)

• 8.1. Definition & Scope
• 8.2. Regional Market Share Analysis, 2023 & 2030
• 8.3. Regional Market Dashboard
• 8.4. Regional Market Snapshot
• 8.5. SWOT Analysis
• 8.6. North America
  • 8.6.1. North America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.6.2. U.S.
    • 8.6.2.1. Key Country Dynamic
    • 8.6.2.2. Regulatory Framework
    • 8.6.2.3. Competitive Insights
    • 8.6.2.4. U.S. Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.6.3. Canada
    • 8.6.3.1. Key Country Dynamic
    • 8.6.3.2. Regulatory Framework
    • 8.6.3.3. Competitive Insights
    • 8.6.3.4. Canada Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
• 8.7. Europe
  • 8.7.1. Europe Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7.2. Germany
    • 8.7.2.1. Key Country Dynamic
    • 8.7.2.2. Regulatory Framework
    • 8.7.2.3. Competitive Insights
    • 8.7.2.4. Germany Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7.3. UK
    • 8.7.3.1. Key Country Dynamic
    • 8.7.3.2. Regulatory Framework
    • 8.7.3.3. Competitive Insights
    • 8.7.3.4. UK Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7.4. France
    • 8.7.4.1. Key Country Dynamic
    • 8.7.4.2. Regulatory Framework
    • 8.7.4.3. Competitive Insights
    • 8.7.4.4. France Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7.5. Italy
    • 8.7.5.1. Key Country Dynamic
    • 8.7.5.2. Regulatory Framework
    • 8.7.5.3. Competitive Insights
    • 8.7.5.4. Italy Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7.6. Spain
    • 8.7.6.1. Key Country Dynamic
    • 8.7.6.2. Regulatory Framework
    • 8.7.6.3. Competitive Insights
    • 8.7.6.4. Spain Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7.7. Denmark
    • 8.7.7.1. Key Country Dynamic
    • 8.7.7.2. Regulatory Framework
    • 8.7.7.3. Competitive Insights
    • 8.7.7.4. Denmark Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7.8. Sweden
    • 8.7.8.1. Key Country Dynamic
    • 8.7.8.2. Regulatory Framework
    • 8.7.8.3. Competitive Insights
    • 8.7.8.4. Sweden Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7.9. Norway
    • 8.7.9.1. Key Country Dynamic
    • 8.7.9.2. Regulatory Framework
    • 8.7.9.3. Competitive Insights
    • 8.7.9.4. Norway Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
• 8.8. Asia Pacific
  • 8.8.1. Asia Pacific Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.8.2. Japan
    • 8.8.2.1. Key Country Dynamic
    • 8.8.2.2. Regulatory Framework
    • 8.8.2.3. Competitive Insights
    • 8.8.2.4. Japan Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.8.3. China
    • 8.8.3.1. Key Country Dynamic
    • 8.8.3.2. Regulatory Framework
    • 8.8.3.3. Competitive Insights
    • 8.8.3.4. China Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.8.4. India
    • 8.8.4.1. Key Country Dynamic
    • 8.8.4.2. Regulatory Framework
    • 8.8.4.3. Competitive Insights
    • 8.8.4.4. India Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.8.5. South Korea
    • 8.8.5.1. Key Country Dynamic
    • 8.8.5.2. Regulatory Framework
    • 8.8.5.3. Competitive Insights
    • 8.8.5.4. South Korea Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.8.6. Australia
    • 8.8.6.1. Key Country Dynamic
    • 8.8.6.2. Regulatory Framework
    • 8.8.6.3. Competitive Insights
    • 8.8.6.4. Australia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.8.7. Thailand
    • 8.8.7.1. Key Country Dynamic
    • 8.8.7.2. Regulatory Framework
    • 8.8.7.3. Competitive Insights
    • 8.8.7.4. Thailand Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
• 8.9. Latin America
  • 8.9.1. Latin America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.9.2. Brazil
    • 8.9.2.1. Key Country Dynamic
    • 8.9.2.2. Regulatory Framework
    • 8.9.2.3. Competitive Insights
    • 8.9.2.4. Brazil Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.9.3. Mexico
    • 8.9.3.1. Key Country Dynamic
    • 8.9.3.2. Regulatory Framework
    • 8.9.3.3. Competitive Insights
    • 8.9.3.4. Mexico Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.9.4. Argentina
    • 8.9.4.1. Key Country Dynamic
    • 8.9.4.2. Regulatory Framework
    • 8.9.4.3. Competitive Insights
    • 8.9.4.4. Argentina Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
• 8.10. MEA
  • 8.10.1. MEA Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.10.2. South Africa
    • 8.10.2.1. Key Country Dynamic
    • 8.10.2.2. Regulatory Framework
    • 8.10.2.3. Competitive Insights
    • 8.10.2.4. South Africa Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.10.3. Saudi Arabia
    • 8.10.3.1. Key Country Dynamic
    • 8.10.3.2. Regulatory Framework
    • 8.10.3.3. Competitive Insights
    • 8.10.3.4. Saudi Arabia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.10.4. UAE
    • 8.10.4.1. Key Country Dynamic
    • 8.10.4.2. Regulatory Framework
    • 8.10.4.3. Competitive Insights
    • 8.10.4.4. UAE Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.10.5. Kuwait
    • 8.10.5.1. Key Country Dynamic
    • 8.10.5.2. Regulatory Framework
    • 8.10.5.3. Competitive Insights
    • 8.10.5.4. Kuwait Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)

Chapter 9. AI In Oncology Market - Competitive Analysis

• 9.1. Recent Developments & Impact Analysis, by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Profiles
  • 9.3.1. Azra AI
    • 9.3.1.1. Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. IBM
    • 9.3.2.1. Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Siemens Healthcare GmbH
    • 9.3.3.1. Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Intel Corporation
    • 9.3.4.1. Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. GE HealthCare
    • 9.3.5.1. Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. NVIDIA Corporation
    • 9.3.6.1. Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Digital Diagnostics Inc.
    • 9.3.7.1. Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. ConcertAI
    • 9.3.8.1. Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Median Technologies
    • 9.3.9.1. Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. PathAI
    • 9.3.10.1. Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Service Benchmarking
    • 9.3.10.4. Strategic Initiatives